Sodium Phenylbutyrate
NDC 49884-170, Sodium Phenylbutyrate Tablets, 500 mg, tablet, from Par Health USA, LLC.
- Product NDC
- 49884-170
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204395
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49884-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM PHENYLBUTYRATE500 mg/1
Pharmacologic classes
Ammonium Ion Binding Activity [MoA]; Nitrogen Binding Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49884-170-04 | 49884017004 | 1 BOTTLE in 1 CARTON (49884-170-04) / 250 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4020b962-eaee-4184-b04b-14ca757c51a1
Use it
Look up 49884-170 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49884-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49884-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.